Pirfenidone alleviates smoke inhalation lung injury of rats via the NF‐κB signaling pathway
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Tingting Lv und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Beijing Luhe Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Pyridones, NF-kappa B, Signal Transduction, Smoke Inhalation Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Objective
Smoke inhalation lung injury (SILI) is a common complication in fires and wars, characterized by acute onset and severe condition. Pirfenidone (PFD), a new small‐molecule drug, has been shown to improve lung function and inhibit pulmonary fibrosis and inflammation. This study aimed to elucidate the effect and underlying mechanism of PFD on SILI in rats. Materials and Methods SILI rats were constructed using a homemade smoking device, which was then treated with PFD. The blood was collected from the abdominal aorta, and the arterial blood gas was detected. The productions of oxidative stress markers and inflammatory cytokines in plasma were measured by enzyme linked immunosorbent assay assay. Moreover, the alveolar surface area, wet:dry weight ratio of the lung tissues, and bronchoalveolar lavage fluid (BALF) were determined as well. The pulmonary histopathology, cell apoptosis, and the related proteins of nuclear factor kappa B (NF‐κB) pathway were determined by hematoxylin‐eosin staining, TdT‐mediated dUTP‐biotin nick end labeling, and western blot assays, respectively.
Results
PFD had a significant protective effect on SILI via inhibiting oxidative stress, inflammation, and apoptosis. Mechanistically, PFD inhibited the activation of NF‐κB pathway in vivo. Moreover, activation of NF‐κB pathway attenuated the PFD‐mediated protective effect against SILI.
Conclusions
These data demonstrate that PFD alleviates SILI of rats via the NF‐κB signaling pathway, which provides an attractive therapeutic option for SILI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Jinxiang Wang
Förderung
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Lv, T., Yang, K., & Wang, J. (2024). Pirfenidone alleviates smoke inhalation lung injury of rats via the NF‐κB signaling pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70014
Vancouver
Lv T, Yang K, Wang J. Pirfenidone alleviates smoke inhalation lung injury of rats via the NF‐κB signaling pathway. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70014
BibTeX
@article{Lv2024,
author = {Lv, Tingting and Yang, Kaiyuan and Wang, Jinxiang},
title = {Pirfenidone alleviates smoke inhalation lung injury of rats via the NF‐κB signaling pathway},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.70014}
}
EUVIMED